Can adults in their 40s contract Respiratory Syncytial Virus (RSV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

RSV Infection in Adults in Their 40s

Yes, adults in their 40s can and do contract RSV, though it typically causes mild to moderate illness in this age group unless specific risk factors are present.

Frequency and Recognition of RSV in Adults

RSV infects all age groups throughout life, with community-based studies estimating yearly incidence at 3-7% in older adults, though the infection is largely underdetected and underestimated in the adult population. 1, 2

  • RSV is identified in 6-11% of outpatient respiratory tract infection consultations in older adults and accounts for 4-11% of adults hospitalized with respiratory tract infections 2
  • All RSV infections in adults represent reinfection, as immunity from childhood infection is incomplete 3
  • The infection often goes unrecognized in adults unless highly sensitive molecular diagnostic tests (PCR) are used, as viral culture and antigen detection are insensitive due to lower viral titers in adult nasal secretions 4, 3, 5

Clinical Presentation in Adults

RSV infection in adults typically presents with:

  • Nasal congestion 4, 5
  • Cough 4, 5
  • Wheezing (commonly noted) 3, 5
  • Low-grade fever 4, 5
  • Chest radiographs are often normal despite significant lower respiratory symptoms and hypoxia 3

Distinguishing RSV from other acute viral infections on clinical grounds alone is not possible with sufficient precision to be clinically useful. 2

Risk Stratification for Adults in Their 40s

Low-Risk Adults (No Comorbidities)

Adults in their 40s without underlying conditions typically experience mild to moderate illness that is self-limited 3

High-Risk Adults (With Comorbidities)

Adults in their 40s with the following conditions are at significantly higher risk for severe RSV disease:

  • Chronic lung disease (COPD, asthma, interstitial lung disease) 6, 4
  • Chronic cardiovascular disease (heart failure, coronary artery disease, congenital heart disease) 6
  • Severe immunocompromise (bone marrow transplant recipients, solid organ transplant recipients) 4, 3, 5
  • Severe obesity (BMI ≥40 kg/m²) 6
  • Diabetes with complications (requiring insulin or with end-organ damage) 6
  • End-stage renal disease or dialysis dependence 6
  • Chronic liver disease (cirrhosis) 6

Vaccination Considerations for Adults in Their 40s

Currently, RSV vaccines are NOT routinely recommended for adults in their 40s. The 2024 ACIP guidelines focus on adults aged ≥60 years 6, 7

Exception for Ages 50-59

  • Only RSVPreF3 (Arexvy) is FDA-approved for adults aged 50-59 years with specific risk factors that increase risk for RSV disease 7, 8
  • This would apply to individuals in their late 40s approaching 50 who have qualifying chronic conditions 8

Important Clinical Pitfalls

The major pitfall is underdiagnosis: Most adult RSV disease goes unrecognized because standard viral culture and antigen detection tests are insensitive in adults 4, 5. PCR testing is the reference standard but is not always performed 2.

Testing from a single respiratory tract site can result in underdetection, so consider multiple sampling sites if clinical suspicion is high 2.

Do not assume absence of fever rules out RSV: Adults with RSV frequently present without fever, unlike influenza 2.

References

Research

Respiratory syncytial virus infection in adult populations.

Infectious disorders drug targets, 2012

Research

Respiratory syncytial virus infection in adults.

Clinical microbiology reviews, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

RSV Vaccination Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

RSV Vaccination Guidelines for Adults with Risk Factors

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.